Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance, According to Hagens Berman
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.